Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I/II Study Evaluating the Safety and Efficacy of Intravenous POL6326 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients With Advanced Hematological Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01413568
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:59.047334+00:00
Published At
2016-02-26T00:00:00+00:00
Record Updated At
2016-02-26
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Acute Myeloid Leukemia in Remission", "Adult Acute Lymphoblastic Leukemia in Remission", "Chronic Myelogenous Leukemia (CML)", "Non-Hodgkin\u0027s Lymphoma (NHL) or Hodgkin\u0027s Disease (HD) in 2nd or Greater Complete Remission, Partial Remission", "Chronic Lymphocytic Leukemia (CLL)", "Multiple Myeloma (MM)", "Myelodysplastic Syndrome (MDS)", "Myeloproliferative Disorders"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-02-26"
protocolSection.identificationModule.nctId
"NCT01413568"
protocolSection.identificationModule.officialTitle
"A Phase I/II Study Evaluating the Safety and Efficacy of Intravenous POL6326 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients With Advanced Hematological Malignancies"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Acute Myeloid Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Adult Acute Lymphoblastic Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Chronic Myelogenous Leukemia (CML) (protocolSection.conditionsModule.conditions)
  • Non-Hodgkin's Lymphoma (NHL) or Hodgkin's Disease (HD) in 2nd or Greater Complete Remission, Partial Remission (protocolSection.conditionsModule.conditions)
  • Chronic Lymphocytic Leukemia (CLL) (protocolSection.conditionsModule.conditions)
  • Multiple Myeloma (MM) (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndrome (MDS) (protocolSection.conditionsModule.conditions)
  • Myeloproliferative Disorders (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.